Clinical Trial Update: A Research Study of a New Medicine NNC0113-6856 in Healthy Males [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reports the completion of Novo Nordisk's NNC0113-6856 in healthy male volunteers. The study lists Type 2 Diabetes as a condition s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0113-6856

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Type 2 Diabetes | Phase 1 | Status: COMPLETED